Well, that's not going to work. Teva's latest move to try to fend off Copaxone copies, a lawsuit against the FDA, got tossed Wednesday by a federal judge in Washington just 10 days before the med's patent expiration date.
written on 15.05.2014
U.S. court bats away Teva's last-ditch pitch against Copaxone generics
